1232. Efficacy and Safety of Intravenous Sulopenem Followed by Oral Sulopenem etzadroxil/Probenecid Versus Intravenous Ertapenem Followed by Oral Ciprofloxacin or Amoxicillin-clavu...

por Dunne, Michael W, Aronin, Steven I
Publicado 2020

2106. Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI)

por Aronin, Steven I, Dunne, Michael W, Gupta, Jayanti, Puttagunta, Sailaja
Publicado 2023

Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for Enterobacterales Isolates

por Puttagunta, Sailaja, Aronin, Steven I., DiFranco-Fisher, Jeanna, Koeth, Laura
Publicado 2023

Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales

por Dunne, Michael W., Puttagunta, Sailaja, Aronin, Steven I., Brossette, Stephen, Murray, John, Gupta, Vikas
Publicado 2022

A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011–2020

por Dunne, Michael W., Aronin, Steven I., Yu, Kalvin C., Watts, Janet A., Gupta, Vikas
Publicado 2022

LB-1. Efficacy and Safety of Oral Sulopenem Etzadroxil/Probenecid Versus Oral Ciprofloxacin in the Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women: Result...

por Dunne, Michael W, Das, Anita F, Zelasky, Michael, Akinapelli, Karthik, Boucher, Helen, Aronin, Steven I
Publicado 2020

In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program

por Maher, Joshua M, Huband, Michael D, Blankers, Christopher G, Puttagunta, Sailaja, Aronin, Steven I, Castanheira, Mariana
Publicado 2023

Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial

por Dunne, Michael W, Aronin, Steven I, Das, Anita F, Akinapelli, Karthik, Breen, Jeanne, Zelasky, Michael T, Puttagunta, Sailaja
Publicado 2022

1724. Murine Efficacy Studies of Sulopenem Against Bacillus anthracis

por Puttagunta, Sailaja, Aronin, Steven I, Dunne, Michael, Halasohoris, Stephanie A, Babyak, Ashley, Hourihan, Mary K, Meinig, James M
Publicado 2022

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial

por Dunne, Michael W, Aronin, Steven I, Das, Anita F, Akinapelli, Karthik, Zelasky, Michael T, Puttagunta, Sailaja, Boucher, Helen W
Publicado 2022

Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections

por Dunne, Michael W, Aronin, Steven I, Das, Anita F, Gupta, Jayanti, Akinapelli, Karthik, Breen, Jeanne, Zelasky, Michael T, Puttagunta, Sailaja
Publicado 2023

Applying Desirability of Outcome Ranking End Points

por Dunne, Michael W, Aronin, Steven I, Das, Anita F, Gupta, Jayanti, Akinapelli, Karthik, Zelasky, Michael T, Puttagunta, Sailaja, Boucher, Helen W
Publicado 2023

2569. Pharmacokinetic-Pharmacodynamic Evaluation of Sulopenem Using a Five-Day Hollow-Fiber In Vitro Infection Model

por VanScoy, Brian D, Conde, Haley, Vincent, Catherine E, Bhavnani, Sujata M, Aronin, Steven I, Puttagunta, Sailaja, Ambrose, Paul G
Publicado 2023

A depiction of imported malaria in Connecticut

por Chia, David, Moreno, Jorge O., Aronin, Steven I., Suarez, Rassull, Virata, Michael D., Igwe, Chinedu A., Quentzel, Howard, Sadigh, Majid
Publicado 2014

2568. Characterization of Sulopenem Pharmacokinetics-Pharmacodynamics Using a One-Compartment In Vitro Infection Model

por VanScoy, Brian D, Jones, Sean, Conde, Haley, Vincent, Catherine E, Bhavnani, Sujata M, Rubino, Christopher M, Aronin, Steven I, Puttagunta, Sailaja, Ambrose, Paul G
Publicado 2023